Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Jyvaskyla – page 2

35 clinical trials in Jyvaskyla, Finland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Jyvaskyla at a glance
35
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

35 trials in Jyvaskyla

Open in trial search

Prostate cancer

Recruiting

Study on Estradiol and Exercise to Reduce Side Effects of Androgen Deprivation Therapy in Prostate Cancer Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Estradiol
  • Sponsor:Varsinais-Suomen hyvinvointialue

Prostate cancer+1

Recruiting

Study on Atorvastatin's Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Pirkanmaan hyvinvointialue

Embolism venous

Not yet recruiting

Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-Yhtymae

Appendicitis

Not yet recruiting

Study on Antibiotic Treatment for Uncomplicated Acute Appendicitis Using Levofloxacin, Ertapenem, and Moxifloxacin in Adult Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Ertapenem
  • Sponsor:Turku University Hospital

Appendicitis

Not yet recruiting

Study on Moxifloxacin for Treating Uncomplicated Acute Appendicitis in Adults

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Moxifloxacin
  • Sponsor:Turku University Hospital

Endometriosis

Not yet recruiting

Study on Cabergoline for Pain and Fertility in Women with Endometriosis and Infertility

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Cabergoline
  • Sponsor:Turku University Hospital

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Jyvaskyla

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on atherosclerotic cardiovascular disease and stroke prevention. Studies evaluate new treatments for heart failure and examine the effectiveness of medications for preventing major cardiac events.

  • Stroke Prevention in Atrial Fibrillation
  • Heart Failure Management
  • Coronary Artery Disease Treatment

Advanced research includes evaluation of novel anticoagulants and cardiac interventions for high-risk patients.

02 Immunology and Vaccines

Clinical studies examining meningococcal vaccines and influenza protection in various age groups. Research focuses on vaccine safety and immune response in different populations.

  • Meningococcal Prevention
  • High-dose Influenza Vaccines
  • Pediatric Vaccine Studies

Emphasis on developing effective immunization strategies for vulnerable populations.

03 Metabolic and Digestive Disorders

Comprehensive research into obesity management and gastrointestinal conditions. Studies include innovative treatments for celiac disease and weight management approaches.

  • Obesity Treatment
  • Celiac Disease Management
  • Gastrointestinal Health

Trials explore both medication-based and surgical interventions for various metabolic conditions.

04 Oncology Studies

Advanced research in prostate cancer treatment and renal cell carcinoma management. Studies evaluate new therapeutic approaches and post-surgical treatments.

  • Prostate Cancer Therapy
  • Renal Cell Carcinoma Treatment
  • Cancer Immunotherapy

Focus on developing targeted therapies and improving treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.